Ubs Group Ag Veru Inc. Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025

A detailed history of Ubs Group Ag transactions in Veru Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,654,591 shares of VERU stock, worth $5.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,654,591
Previous 1,966,781 15.87%
Holding current value
$5.71 Million
Previous $963,000 0.42%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$0.49 - $0.7 $152,973 - $218,533
-312,190 Reduced 15.87%
1,654,591 $959,000
Q1 2025

May 13, 2025
BUY
$0.45 - $1.28 $683,197 - $1.94 Million
1,518,216 Added 338.46%
1,966,781 $963,000
Q4 2024

Feb 14, 2025
BUY
$0.58 - $0.93 $222,800 - $357,248
384,138 Added 596.24%
448,565 $291,000
Q3 2024

Nov 14, 2024
BUY
$0.77 - $1.04 $17,052 - $23,031
22,146 Added 52.38%
64,427 $49,000
Q2 2024

Aug 13, 2024
BUY
$0.76 - $1.79 $30,033 - $70,737
39,518 Added 1430.26%
42,281 $35,000
Q1 2024

May 13, 2024
SELL
$0.37 - $0.72 $5,390 - $10,489
-14,569 Reduced 84.06%
2,763 $1,000
Q4 2023

Feb 09, 2024
BUY
$0.67 - $1.17 $9,401 - $16,417
14,032 Added 425.21%
17,332 $12,000
Q3 2023

Nov 09, 2023
SELL
$0.72 - $1.33 $16,863 - $31,151
-23,422 Reduced 87.65%
3,300 $2,000
Q2 2023

Aug 11, 2023
SELL
$0.98 - $1.49 $19 - $29
-20 Reduced 0.07%
26,722 $31,000
Q1 2023

May 12, 2023
SELL
$1.16 - $6.41 $27,406 - $151,442
-23,626 Reduced 46.91%
26,742 $31,000
Q4 2022

Feb 08, 2023
BUY
$4.78 - $15.01 $80,217 - $251,897
16,782 Added 49.97%
50,368 $265,000
Q3 2022

Nov 10, 2022
SELL
$10.22 - $23.7 $57,538 - $133,431
-5,630 Reduced 14.36%
33,586 $387,000
Q2 2022

Aug 10, 2022
BUY
$4.35 - $15.85 $3,871 - $14,106
890 Added 2.32%
39,216 $443,000
Q1 2022

May 16, 2022
SELL
$4.55 - $6.41 $118,937 - $167,557
-26,140 Reduced 40.55%
38,326 $185,000
Q4 2021

Feb 14, 2022
BUY
$5.89 - $9.73 $71,905 - $118,783
12,208 Added 23.36%
64,466 $380,000
Q3 2021

Nov 15, 2021
SELL
$6.78 - $9.89 $262,202 - $382,475
-38,673 Reduced 42.53%
52,258 $446,000
Q2 2021

Aug 13, 2021
BUY
$7.24 - $11.2 $194,929 - $301,548
26,924 Added 42.06%
90,931 $734,000
Q1 2021

May 12, 2021
SELL
$8.05 - $20.78 $18,845 - $48,645
-2,341 Reduced 3.53%
64,007 $689,000
Q4 2020

Feb 11, 2021
BUY
$2.36 - $9.99 $7,606 - $32,197
3,223 Added 5.11%
66,348 $574,000
Q3 2020

Nov 12, 2020
SELL
$2.58 - $3.36 $37,649 - $49,032
-14,593 Reduced 18.78%
63,125 $165,000
Q2 2020

Jul 31, 2020
BUY
$3.01 - $4.02 $43,118 - $57,586
14,325 Added 22.6%
77,718 $260,000
Q1 2020

May 01, 2020
BUY
$2.58 - $4.58 $127,898 - $227,044
49,573 Added 358.7%
63,393 $207,000
Q4 2019

Feb 14, 2020
SELL
$1.86 - $3.35 $9,022 - $16,250
-4,851 Reduced 25.98%
13,820 $46,000
Q3 2019

Nov 14, 2019
SELL
$1.81 - $2.36 $2,018 - $2,631
-1,115 Reduced 5.64%
18,671 $41,000
Q2 2019

Aug 14, 2019
BUY
$1.26 - $2.14 $7,617 - $12,938
6,046 Added 44.0%
19,786 $42,000
Q1 2019

May 14, 2019
SELL
$1.2 - $1.59 $6,562 - $8,695
-5,469 Reduced 28.47%
13,740 $20,000
Q4 2018

Feb 14, 2019
BUY
$1.21 - $1.54 $3,075 - $3,914
2,542 Added 15.25%
19,209 $27,000
Q3 2018

Nov 14, 2018
BUY
$1.38 - $2.27 $4,039 - $6,644
2,927 Added 21.3%
16,667 $24,000
Q2 2018

Aug 14, 2018
SELL
$1.64 - $2.29 $10,728 - $14,981
-6,542 Reduced 32.26%
13,740 $28,000
Q1 2018

May 15, 2018
SELL
$1.19 - $2.17 $264 - $481
-222 Reduced 1.08%
20,282 $36,000
Q4 2017

Feb 14, 2018
SELL
$0.98 - $2.27 $757 - $1,754
-773 Reduced 3.63%
20,504 $23,000
Q3 2017

Nov 14, 2017
BUY
$1.2 - $2.84 $25,532 - $60,426
21,277
21,277 $56,000

Others Institutions Holding VERU

# of Institutions
137
Shares Held
44M
Call Options Held
50.5K
Put Options Held
824K
View Full List

About VERU INC.

VERU Quotes by TradingView
  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $277M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email